TABLE 3.
Predictors of cure rate at weeks four and week eight of post single dose praziquantel administrations.
Variables | Cured N (%) | Week 4 | Week 8 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||||
cOR (95% CI) | p | aOR (95% CI) | p | cOR (95% CI) | p | aOR (95% CI) | p | |||
Intensity of infection | Light | 328 (91.1) | ||||||||
Moderate-to-Heavy | 124 (84.4) | 0.53 (0.3–0.9) | 0.028 | 0.5 (0.3–0.9) | 0.028 | 0.4 (0.2–0.7) | 0.002 | 0.4 (0.2–0.7) | 0.002 | |
Age group | 5–9 | 96 (85.7) | 0.7 (0.4–1.2) | 0.18 | 0.7 (0.3–1.2) | 0.18 | 0.4 (0.2–0.8) | 0.013 | 0.4 (0.2–0.8) | 0.012 |
10–15 | 356 (90.1) | |||||||||
Sex | Male | 228 (90.1) | 0.8 (0.5–1.4) | 0.48 | 0.99 (0.5–1.9) | 0.98 | ||||
Female | 224 (88.2) | |||||||||
STH infection | Yes | 268 (89.0) | ||||||||
No | 184 (89.3) | 1 (0.6–1.8) | 0.92 | 1.1 (0.6–2.1) | 0.68 | |||||
HAZ | Normal | 411 (88.8) | ||||||||
Stunted | 41 (93.2) | 1.3 (0.7–2.7) | 0.44 | 1.3 (0.7–2.4) | 0.442 | |||||
BAZ | Normal | 380 (89.6) | ||||||||
Wasted | 72 (86.8) | 0.6 (0.2–1.9) | 0.37 | 0.6 (0.2–1.9) | 0.372 |
COR, crude odd ratio; AOR, Adjusted odd ratio; CI, Confidence Interval; Significant values are indicated in bold.